Salvage Immunotherapy and Chemotherapy in Esophageal Squamous Cell Carcinoma Patients Nonresponding to Initial Neoadjuvant Chemoradiotherapy
Clinical trial NCT05103501 · UNKNOWN
Trial details
- NCT number
- NCT05103501
- Sponsor
- Shanghai Chest Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2023-09-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.